CMIC partners with Align Clinical to develop open technology standards for clinical trials. Credit: Michal Jarmoluk from Pixabay.

CMIC Group has partnered with Align Clinical to create open technology standards that make it easier for sponsors and contract research organisations (CRO) to work collaboratively during trials.

CMIC is the first Japan-based CRO to join the group. It has an expertise of more than 25 years as a solution provider and clinical trial operational expertise in Asia.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The company is collaborating with leading CRO partners to enhance execution and partnership with life sciences companies during clinical trials.

As a provider of end-to-end solutions from preclinical to clinical phase, from drug development to manufacturing stage, and from filing to post marketing surveillance, CMIC acts as a strategic partner to help sponsors develop better medicines faster.

CMIC Holdings president and COO Keiko Oishi said: “The global healthcare industry is going through significant change. The types of service requests and qualification requirements are changing, the number of global trials is increasing, and study designs are more complex.

“As a member of Align Clinical CRO, CMIC is committed to helping the industry increase productivity, reduce operational costs, and run clinical trials more efficiently.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Founded by Veeva Systems, Align Clinical is  engaged in the improvisation of clinical trial execution and collaboration with life sciences companies.

Established in 1992, CMIC provides comprehensive support services for the development, manufacturing, sales, and marketing of pharmaceutical products. It develops and sells diagnostic pharmaceuticals and orphan drugs.

The group has developed pharmaceutical value creator (PVC) business model which is based on its experience and knowledge as a CRO pioneer.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact